Journey Medical
DERM
20 hedge funds and large institutions have $2.63M invested in Journey Medical in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
18% more funds holding
Funds holding: 17 → 20 (+3)
0.73% less ownership
Funds ownership: 14.35% → 13.63% (-0.73%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
95% less capital invested
Capital invested by funds: $51.4M → $2.63M (-$48.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BJL
Brighton Jones LLC
Seattle,
Washington
|
+$37K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$19.3K |
| 3 |
Renaissance Technologies
New York
|
+$18.5K |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$12.9K |
| 5 |
BlackRock
New York
|
+$10.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
-$48.8M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$54.1K |
| 3 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$34.3K |
| 4 |
WAAG
Wealth Alliance Advisory Group
Wichita,
Kansas
|
-$16.9K |
| 5 |
Neuberger Berman Group
New York
|
-$14.4K |
DERM Hedge Fund Activity: Q2 2023 in Review
20 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q2 2023, worth a combined $2.63M — down 95% from $51.4M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new DERM positions and 2 closed out — a net gain of 3 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Brighton Jones LLC, opening a new position worth an estimated $37K. The largest seller was Cerity Partners, exiting entirely with an estimated $48.8M sold.
- 20 institutional investors held Journey Medical (DERM) as of Q2 2023, up from 17 in Q1 2023.
- Funds reported $2.63M of Journey Medical stock for Q2 2023, down 95% quarter-over-quarter.
- 5 funds opened new Journey Medical positions in Q2 2023 and 2 closed out, a net change of +3 holders.
- The largest Journey Medical buyer in Q2 2023 was Brighton Jones LLC, an estimated $37K added.
- The largest Journey Medical seller in Q2 2023 was Cerity Partners, an estimated $48.8M sold.
Based on aggregated 13F filings for Q2 2023.